Home » U.S. FDA: Releasing More Trial Data Could Hasten Medtech Development
U.S. FDA: Releasing More Trial Data Could Hasten Medtech Development
July 2, 2013
The U.S. Food and Drug Administration is considering making available more masked and de-identified safety and efficacy data from clinical and preclinical trials to boost opportunities for innovative development of medical technologies.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor